CTRI/2022/01/039444
Recruiting
Phase 2
Safety and efficacy of Nicorandil in Peripheral Vascular Disease: An exploratory randomized controlled trial
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: I739- Peripheral vascular disease, unspecified
- Sponsor
- All India Institute of Medical Sciences Rishikesh
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Newly diagnosed patients with intermittent claudication (according to Edinburgâ??s Claudication Questionnaire1 )\- suggestive of Peripheral vascular disease
- •2\.Patients already diagnosed as case of Peripheral vascular disease with clinical and radiological evidence suggestive of chronic limb ischemia/ PVD
- •3\.Age \> 18 years to 65 years
- •4\.Pain involving either single limb or both lower limbs
Exclusion Criteria
- •1\.Acute limb ischemia
- •2\.Acute on chronic limb ischemia
- •3\.Patients with connective tissues disorders with vasculitis
- •4\.Have a neurological condition other than that associated with their pain diagnosis which, in the opinion of the investigator, would interfere with their ability to participate in the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
Clinical Efficacy and SAfety of Intravenous Infusion of Nicorandil During Primary Percutaneous Coronary InterventionST Elevation Myocardial InfarctionPercutaneous Coronary InterventionNCT04665648Fudan University1,500
Recruiting
Phase 3
Effect of Nicorandil on contrast-induced nephropathycontrast-induced nephropathy.Nephropathy induced by other drugs, medicaments and biological substancesICD 10- N1IRCT20230110057096N1Rasht University of Medical Sciences264
Active, not recruiting
Not Applicable
The effect of intracoronary nicorandil in improving coronary blood flow during primary angioplastyHealth Condition 1: I219- Acute myocardial infarction, unspecifiedHealth Condition 2: I219- Acute myocardial infarction, unspecifiedCTRI/2018/10/015937Dr Sreejith A G
Completed
Not Applicable
the efficacy of nicorandil in percutaneouns coronary intervention post procedure MI studyAngina PectorisJPRN-UMIN000027846Tsukazaki Hospital Department of Cardiology100
Completed
Not Applicable
To study the efficacy of Niconrandil drug as an add-on treatment to the standard care given to the patient with acute ischemic strokeHealth Condition 1: G94- Other disorders of brain in diseases classified elsewhereCTRI/2022/01/039227SRMIST19